Regulation of Candida albicans gene expression in response to host environmental stresses
白色念珠菌基因表达响应宿主环境胁迫的调节
基本信息
- 批准号:10867738
- 负责人:
- 金额:$ 58.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos Untranslated RegionsAcquired Immunodeficiency SyndromeAddressAffectAntibioticsAntifungal AgentsBindingBinding ProteinsBioinformaticsBiological AssayCancer PatientCandida albicansCandidiasisCell WallCell membraneComplexCryptococcus neoformansDefectDevelopmentDisseminated candidiasisEIF-2alphaEnvironmentEpitopesEukaryotic Initiation Factor-4FFungal Drug ResistanceGene ExpressionGenesGenetic TranscriptionGoalsGrowthHIV/AIDSHospitalsHumanImmuneImmunocompromised HostIndividualInfectionLinkMacrophageMediatingMembraneMessenger RNAMorphologyMucous MembraneMutationOrthologous GeneOsmosisOxidative StressPathogenesisPathogenicityPatientsPhagocytesPhosphorylationPhosphotransferasesPlayPredispositionProcessProteinsPublic HealthRegulationRibosomesRoleSaccharomyces cerevisiaeSepsisSignal PathwayStressStructureSystemic infectionTestingTranscriptTranslational RegulationTranslationsVirulenceYeastsbiological adaptation to stresschemotherapycombatenvironmental stressorexperimental studygenome-widehelicasemRNA cappingmouse modelmutantneutrophilnew therapeutic targetnovelnovel therapeutic interventionorgan transplant recipientpathogenic funguspreventprotein functionresponseribosome profilingtranslation factortreatment strategy
项目摘要
PROJECT SUMMARY/ABSTRACT
Candida albicans is a major human fungal pathogen responsible for a wide variety of systemic and mucosal
infections. Immunocompromised individuals, including organ transplant recipients, AIDS patients and cancer
patients on chemotherapy are highly susceptible to infection. In the host environment C. albicans encounters a
wide variety of environmental stresses, including acidic pH, osmotic/cationic, thermal, oxidative, nitrosative, cell
wall and cell membrane stresses. While transcriptional and post-translational mechanisms that mediate C.
albicans stress responses have been well-characterized, considerably less is known about the role of
translational mechanisms; given that many effective classes of antibiotics target bacterial translation
mechanisms, this remains an unexplored and unexploited avenue for antifungal development. The eIF4F
translation initiation complex is important for binding to the 5' CAP of mRNAs and contains helicase activity
that unwinds complex secondary structures in 5' untranslated regions (UTRs) to promote translation and
ribosome accessibility. We have recently demonstrated that fungal-specific C. albicans orthologs of the yeast
eIF4E-binding proteins Eap1 and Caf20, which function as negative regulators of the eIF4F complex, play an
important role in controlling oxidative and cell wall/cell membrane stress responses. In addition, we have
shown that both C. albicans proteins are down-regulated in response to membrane stress and orf19.7034 (the
Eap1 ortholog) functions as a key negative regulator of P-body formation under multiple stress conditions (P-
bodies are translationally inactive cellular compartments). Using ribosome profiling, we have also recently
demonstrated that the C. albicans morphological transition, and most likely additional virulence processes, is
under widespread global translational control. Based on this evidence, and additional studies, our hypothesis is
that elucidating translational regulatory mechanisms which control the ability of C. albicans to respond to host
environmental stresses will provide a new strategy to identify and characterize potential antifungal targets. To
address this hypothesis, we plan to: 1) determine the global translational profile of C. albicans in response to a
variety of host environmental stress conditions; we will also identify and characterize selected translationally
controlled target genes important for C. albicans stress responses, 2) determine how eIF4E-binding proteins
and components of the eIF4F complex control the ability of C. albicans to respond to host environmental
stresses, 3) determine how translational stress response mechanisms control C. albicans virulence and
pathogenicity using both a mouse model of systemic candidiasis and macrophage/neutrophil killing and
survival assays. These studies will provide a better understanding of global regulatory circuits and individual
factors that control the translational response of C. albicans to host environmental stress conditions. Ultimately,
common fungal-specific translation factors and/or target genes important for stress responses, virulence and
pathogenesis could serve as important targets for the development of novel and more effective antifungals.
项目概要/摘要
白色念珠菌是一种主要的人类真菌病原体,可导致多种系统和粘膜疾病
感染。免疫功能低下的个体,包括器官移植受者、艾滋病患者和癌症患者
化疗患者极易受到感染。在宿主环境中,白色念珠菌遇到
各种环境压力,包括酸性 pH、渗透/阳离子、热、氧化、亚硝化、细胞
壁和细胞膜应力。而介导 C. 的转录和翻译后机制
白色念珠菌的应激反应已被充分表征,但人们对它的作用知之甚少。
翻译机制;鉴于许多有效的抗生素类别都针对细菌翻译
机制,这仍然是抗真菌开发的一个未探索和未开发的途径。 eIF4F
翻译起始复合物对于结合 mRNA 的 5' CAP 很重要,并且含有解旋酶活性
解开 5' 非翻译区 (UTR) 中的复杂二级结构,以促进翻译和
核糖体可及性。我们最近证明了酵母的真菌特异性白色念珠菌直系同源物
eIF4E 结合蛋白 Eap1 和 Caf20 作为 eIF4F 复合物的负调节因子,发挥着
在控制氧化和细胞壁/细胞膜应激反应中发挥重要作用。此外,我们还有
结果表明,两种白色念珠菌蛋白都会因膜应激和 orf19.7034(
Eap1直系同源物)在多种应激条件下(P-body)作为P体形成的关键负调节因子发挥作用
体是翻译不活跃的细胞区室)。使用核糖体分析,我们最近还
证明白色念珠菌形态转变以及最有可能的额外毒力过程是
受到广泛的全球翻译控制。基于这些证据和其他研究,我们的假设是
阐明控制白色念珠菌响应宿主能力的翻译调控机制
环境压力将提供一种新的策略来识别和表征潜在的抗真菌目标。到
为了解决这个假设,我们计划:1)确定白色念珠菌的全球翻译概况,以响应
各种宿主环境应激条件;我们还将通过翻译来识别和表征所选的
对白色念珠菌应激反应很重要的受控靶基因,2) 确定 eIF4E 结合蛋白如何
eIF4F 复合物的组成部分控制白色念珠菌对宿主环境做出反应的能力
应激,3) 确定转化应激反应机制如何控制白色念珠菌毒力和
使用系统性念珠菌病和巨噬细胞/中性粒细胞杀灭小鼠模型进行致病性和
生存分析。这些研究将有助于更好地了解全球监管回路和个人
控制白色念珠菌对宿主环境应激条件的翻译反应的因素。最终,
常见的真菌特异性翻译因子和/或对应激反应、毒力和
发病机制可以作为开发新型且更有效的抗真菌药物的重要目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID KADOSH其他文献
DAVID KADOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID KADOSH', 18)}}的其他基金
Translational Regulation of Candida glabrata Azole Resistance
光滑念珠菌唑耐药性的转化调控
- 批准号:
10681915 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别:
Regulation of Multidrug Resistance in the Emerging Human Fungal Pathogen Candida auris
新兴人类真菌病原体耳念珠菌的多药耐药性调控
- 批准号:
10409832 - 财政年份:2021
- 资助金额:
$ 58.2万 - 项目类别:
Regulation of Multidrug Resistance in the Emerging Human Fungal Pathogen Candida auris
新兴人类真菌病原体耳念珠菌的多药耐药性调控
- 批准号:
10317488 - 财政年份:2021
- 资助金额:
$ 58.2万 - 项目类别:
Translational Control of Morphology and Virulence in Candida albicans
白色念珠菌形态和毒力的转化控制
- 批准号:
9910361 - 财政年份:2018
- 资助金额:
$ 58.2万 - 项目类别:
Translational Control of Morphology and Virulence in Candida albicans
白色念珠菌形态和毒力的转化控制
- 批准号:
10398003 - 财政年份:2018
- 资助金额:
$ 58.2万 - 项目类别:
Determination of morphology and virulence in Candida albicans
白色念珠菌形态和毒力的测定
- 批准号:
8474527 - 财政年份:2010
- 资助金额:
$ 58.2万 - 项目类别:
Determination of morphology and virulence in Candida albicans
白色念珠菌形态和毒力的测定
- 批准号:
7898091 - 财政年份:2010
- 资助金额:
$ 58.2万 - 项目类别:
Determination of morphology and virulence in Candida albicans
白色念珠菌形态和毒力的测定
- 批准号:
8463967 - 财政年份:2010
- 资助金额:
$ 58.2万 - 项目类别:
Determination of morphology and virulence in Candida albicans
白色念珠菌形态和毒力的测定
- 批准号:
8260211 - 财政年份:2010
- 资助金额:
$ 58.2万 - 项目类别:
Determination of morphology and virulence in Candida albicans
白色念珠菌形态和毒力的测定
- 批准号:
8648982 - 财政年份:2010
- 资助金额:
$ 58.2万 - 项目类别:
相似海外基金
Translational Regulation of Candida glabrata Azole Resistance
光滑念珠菌唑耐药性的转化调控
- 批准号:
10681915 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别:
Regulation of Multidrug Resistance in the Emerging Human Fungal Pathogen Candida auris
新兴人类真菌病原体耳念珠菌的多药耐药性调控
- 批准号:
10409832 - 财政年份:2021
- 资助金额:
$ 58.2万 - 项目类别:
Regulation of Multidrug Resistance in the Emerging Human Fungal Pathogen Candida auris
新兴人类真菌病原体耳念珠菌的多药耐药性调控
- 批准号:
10317488 - 财政年份:2021
- 资助金额:
$ 58.2万 - 项目类别:
Evaluation of Self-delivering FANA Antisense Oligonucleotide Lead Compounds for HIV Therapy
自递送 FANA 反义寡核苷酸先导化合物用于 HIV 治疗的评价
- 批准号:
10011742 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别:
Evaluation of Self-delivering FANA Antisense Oligonucleotide Lead Compounds for HIV Therapy
自递送 FANA 反义寡核苷酸先导化合物用于 HIV 治疗的评价
- 批准号:
10232090 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别: